Jianjun Cheng

26PUBLICATIONS
36CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 23, 2026
Sustained antidepressant-like effects of psychedelics through 5-HT2AR-β-arrestin signaling.

|Sep 17, 2026
Structure-based design of subtype-selective psychedelic analogs.

|Sep 17, 2026
Mechanistic Basis for 5-HT2AR Over 5-HT2BR Activation.

|Feb 20, 2026
Pharmacokinetics-Driven Optimization of Immunotherapeutic Agents Targeting the Adenosine A2A Receptor (A2AR) and Histone Deacetylases (HDACs).

Wenzhong Yan, Mingshun Feng, Kexin Yang

|Oct 14, 2025
Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects.

Rongyan Li, Haohan Yan, Yujin Chen

|Nov 30, 2023
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.

Wenwen Duan, Dongmei Cao, Sheng Wang

Pageof 5

Frequent Collaborators

8 joint publications

Sheng Wang

4 joint publications

Suwen Zhao

3 joint publications

Dong Guo

3 joint publications

Zhijie Liu